Sign in or Register   Sign in or Register
  |  

Mouse Anti-MMP14 Recombinant Antibody (CBFYM-0670) (CBMAB-M0806-FY)

This product is mouse antibody that recognizes MMP14. The antibody CBFYM-0670 can be used for immunoassay techniques such as: ELISA, IHC, WB.
See all MMP14 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBFYM-0670
Antibody Isotype
IgG1, k
Application
ELISA, IHC, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1, k
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.2
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Matrix Metallopeptidase 14
Introduction
Proteins of the matrix metalloproteinase family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion.
Entrez Gene ID
4323
UniProt ID
P50281
Alternative Names
Matrix Metallopeptidase 14; Matrix Metallopeptidase 14 (Membrane-Inserted); Membrane-Type-1 Matrix Metalloproteinase; Membrane Type 1 Metalloprotease; EC 3.4.24.80; MT-MMP 1; MT1-MMP; MMP-14; MMP-X1
Function
Endopeptidase that degrades various components of the extracellular matrix such as collagen. Activates progelatinase A. Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity).

May be involved in actin cytoskeleton reorganization by cleaving PTK7 (PubMed:20837484).

Acts as a positive regulator of cell growth and migration via activation of MMP15. Involved in the formation of the fibrovascular tissues in association with pro-MMP2 (PubMed:12714657).

Cleaves ADGRB1 to release vasculostatin-40 which inhibits angiogenesis (PubMed:22330140).
Biological Process
Angiogenesis Source: Ensembl
Astrocyte cell migration Source: Ensembl
Branching morphogenesis of an epithelial tube Source: Ensembl
Cell motility Source: ParkinsonsUK-UCL
Chondrocyte proliferation Source: Ensembl
Collagen catabolic process Source: GO_Central
Craniofacial suture morphogenesis Source: Ensembl
Embryonic cranial skeleton morphogenesis Source: Ensembl
Endochondral ossification Source: Ensembl
Endodermal cell differentiation Source: UniProtKB
Endothelial cell proliferation Source: Ensembl
Extracellular matrix disassembly Source: Reactome
Extracellular matrix organization Source: GO_Central
Head development Source: Ensembl
Lung development Source: Ensembl
Male gonad development Source: Ensembl
Negative regulation of focal adhesion assembly Source: Ensembl
Negative regulation of Notch signaling pathway Source: UniProtKB
Ovarian follicle development Source: Ensembl
Positive regulation of B cell differentiation Source: UniProtKB
Positive regulation of cell growth Source: UniProtKB
Positive regulation of cell migration Source: UniProtKB
Positive regulation of macrophage migration Source: Ensembl
Positive regulation of myotube differentiation Source: UniProtKB
Positive regulation of protein processing Source: Ensembl
Protein processing Source: ParkinsonsUK-UCL
Proteolysis Source: ParkinsonsUK-UCL
Regulation of protein localization to plasma membrane Source: UniProtKB
Response to estrogen Source: Ensembl
Response to hypoxia Source: Ensembl
Response to mechanical stimulus Source: Ensembl
Response to odorant Source: Ensembl
Response to organic cyclic compound Source: Ensembl
Response to oxidative stress Source: Ensembl
Skeletal system development Source: GO_Central
Tissue remodeling Source: Ensembl
Zymogen activation Source: UniProtKB
Cellular Location
Cytoplasm
Other locations
Membrane
Melanosome
Note: Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Forms a complex with BST2 and localizes to the cytoplasm.
Involvement in disease
Winchester syndrome (WNCHRS):
A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes.
Topology
Extracellular: 112-541
Helical: 542-562
Cytoplasmic: 563-582
PTM
The precursor is cleaved by a furin endopeptidase.
Tyrosine phosphorylated by PKDCC/VLK.

Jin, Z., Dridi, N., Palui, G., Palomo, V., Jokerst, J. V., Dawson, P. E., ... & Mattoussi, H. (2023). Evaluating the catalytic efficiency of the human membrane-type 1 matrix metalloproteinase (MMP-14) Using AuNP–Peptide conjugates. Journal of the American Chemical Society, 145(8), 4570-4582.

Kümper, M., Hessenthaler, S., Zamek, J., Niland, S., Pach, E., Mauch, C., & Zigrino, P. (2022). Loss of endothelial cell matrix metalloproteinase 14 reduces melanoma growth and metastasis by increasing tumor vessel stability. Journal of Investigative Dermatology, 142(7), 1923-1933.

Pach, E., Kümper, M., Fromme, J. E., Zamek, J., Metzen, F., Koch, M., ... & Zigrino, P. (2021). Extracellular matrix remodeling by fibroblast-MMP14 regulates melanoma growth. International journal of molecular sciences, 22(22), 12276.

Duan, F., Peng, Z., Yin, J., Yang, Z., & Shang, J. (2020). Expression of MMP-14 and prognosis in digestive system carcinoma: a meta-analysis and databases validation. Journal of Cancer, 11(5), 1141.

Chen, N., Zhang, G., Fu, J., & Wu, Q. (2020). Matrix metalloproteinase‐14 (MMP‐14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation. Thoracic Cancer, 11(11), 3168-3174.

Zhang, L., Jin, S., Wei, Y., Wang, C., Zou, H., Hu, J., ... & Pang, L. (2020). Prognostic Significance of Matrix Metalloproteinase 14 in Patients with Cancer: a Systematic Review and Meta-Analysis. Clinical Laboratory, 86(5).

Miekus, N., Luise, C., Sippl, W., Baczek, T., Schmelzer, C. E., & Heinz, A. (2019). MMP-14 degrades tropoelastin and elastin. Biochimie, 165, 32-39.

Pietraszek-Gremplewicz, K., Karamanou, K., Niang, A., Dauchez, M., Belloy, N., Maquart, F. X., ... & Brezillon, S. (2019). Small leucine-rich proteoglycans and matrix metalloproteinase-14: Key partners?. Matrix Biology, 75, 271-285.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-MMP14 Recombinant Antibody (CBFYM-0670)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare